Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension
Authors
Keywords
-
Journal
CHEST
Volume 162, Issue 6, Pages 1360-1372
Publisher
Elsevier BV
Online
2022-07-14
DOI
10.1016/j.chest.2022.06.042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pseudoephedrine—Benefits and Risks
- (2021) Krystyna Głowacka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pulmonary Arterial Hypertension
- (2021) Paul M. Hassoun NEW ENGLAND JOURNAL OF MEDICINE
- Clopidogrel, a CYP2C8 inhibitor, causes a clinically relevant increase in the systemic exposure to the active metabolite of selexipag in healthy subjects
- (2020) Lene Nygaard Axelsen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacotherapy for pulmonary arterial hypertension
- (2019) Vishal Parikh et al. Journal of Thoracic Disease
- Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
- (2018) Clara Hjalmarsson et al. EUROPEAN RESPIRATORY JOURNAL
- Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications
- (2016) Catia Marzolini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Contribution of CYP3A Isoforms to Dealkylation of PDE5 Inhibitors: A Comparison between Sildenafil N-Demethylation and Tadalafil Demethylenation
- (2015) Rikako Takahiro et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat in Healthy Young Chinese Male Non-Smokers and Smokers: Results of a Randomized, Double-Blind, Placebo-Controlled Study
- (2015) Xia Zhao et al. CLINICAL PHARMACOKINETICS
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN HEART JOURNAL
- PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN RESPIRATORY JOURNAL
- Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
- (2015) Vallerie McLaughlin et al. EUROPEAN RESPIRATORY JOURNAL
- Investigation of the Effects of Ketoconazole on the Pharmacokinetics of Macitentan, a Novel Dual Endothelin Receptor Antagonist, in Healthy Subjects
- (2013) Jacob Atsmon et al. CLINICAL PHARMACOKINETICS
- Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension
- (2013) Jasper Dingemanse et al. Expert Opinion On Drug Safety
- An update on the use of ambrisentan in pulmonary arterial hypertension
- (2012) Michele D’Alto Therapeutic Advances in Respiratory Disease
- Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist
- (2011) Shirin Bruderer et al. AAPS Journal
- Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
- (2011) Jürgen Venitz et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary Hypertension
- (2010) Bryan G. Schwartz et al. CIRCULATION
- Effects of Rifampicin (Rifampin) on the Pharmacokinetics and Safety of Ambrisentan in Healthy Subjects
- (2010) Brooke Harrison et al. CLINICAL DRUG INVESTIGATION
- Pulmonary Arterial Hypertension
- (2009) David B. Badesch et al. CHEST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started